Iridex (IRIX) Net Margin Growth (3y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -315.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,018.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 399.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn | 1,081.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 1,081.00 |
| Jan 3, 2026 | 4,101.00 |
| Sep 27, 2025 | -53.00 |
| Jun 28, 2025 | 897.00 |
| Mar 29, 2025 | 369.00 |
| Dec 28, 2024 | 4,119.00 |
| Sep 28, 2024 | -37.00 |
| Jun 29, 2024 | -3,159.00 |
| Mar 30, 2024 | -1,265.00 |
| Sep 30, 2023 | 588.00 |
| Jul 1, 2023 | 2,318.00 |
| Apr 1, 2023 | 305.00 |
| Dec 31, 2022 | -6,877.00 |
| Oct 1, 2022 | 466.00 |
| Jul 2, 2022 | 691.00 |
| Apr 2, 2022 | 1,091.00 |
| Jan 1, 2022 | -6,496.00 |
| Oct 2, 2021 | 1,083.00 |
| Jul 3, 2021 | 4,221.00 |
| Apr 3, 2021 | 2,108.00 |
| Sep 26, 2020 | 897.00 |
| Jun 27, 2020 | -1,721.00 |
| Mar 28, 2020 | -50.00 |
| Dec 28, 2019 | 14,712.00 |
| Sep 28, 2019 | -988.00 |
| Jun 29, 2019 | -2,045.00 |
| Mar 30, 2019 | -2,961.00 |
| Dec 29, 2018 | 9,306.00 |
| Sep 29, 2018 | -3,166.00 |
| Jun 30, 2018 | -2,461.00 |
| Mar 31, 2018 | -4,017.00 |
| Sep 30, 2017 | -3,334.00 |
| Jul 1, 2017 | -3,030.00 |
| Apr 1, 2017 | -2,252.00 |
| Dec 31, 2016 | -9,020.00 |
| Jan 2, 2016 | -3,222.00 |
| Oct 3, 2015 | 691.00 |
| Apr 4, 2015 | 423.00 |
| Jun 28, 2014 | 244.00 |